Literature DB >> 16283987

Modelling the natural history of geographic atrophy in patients with age-related macular degeneration.

J Dreyhaupt1, U Mansmann, M Pritsch, J Dolar-Szczasny, A Bindewald, F G Holz.   

Abstract

PURPOSE: To model the natural course of geographic atrophy (GA) in patients with age-related macular degeneration (AMD).
METHODS: Data on the natural course of GA were collected in the multi-center, longitudinal, prospective observational FAM study. The size of GA was measured by autofluorescence scanning laser ophthalmoscopy. The natural course of GA is modelled by two different mixed effect models (MEM). Both models are compared with respect to the correctness of the model assumptions, goodness of fit, and predictive behavior.
RESULTS: The linear model results in better prediction, the non-linear model is more in agreement with the model assumptions. The non-linear model fits the data for small and large areas of GA better, while the linear model seems to be more adequate for the medial areas. More data will be needed to study the interplay of both models in more detail.
CONCLUSIONS: The natural course of GA varies extremely between individuals. However, reliable factors for the explanation of this variability have so far not been established. MEM are useful for describing "inter-individual" as well as "intra-individual" influences without the need for precise knowledge of the influencing factors. Using MEM to evaluate data on the natural history of GA allows one to derive parameter estimates, which could be used to design interventional trials for modes of therapy with a potential to reduce or stop the progression of GA in patients with AMD.

Entities:  

Mesh:

Year:  2005        PMID: 16283987     DOI: 10.1080/09286580591005723

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  18 in total

1.  Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry.

Authors:  Annal D Meleth; Pradeep Mettu; Elvira Agrón; Emily Y Chew; Srinivas R Sadda; Frederick L Ferris; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-28       Impact factor: 4.799

2.  New grading criteria allow for earlier detection of geographic atrophy in clinical trials.

Authors:  Hilary Smolen Brader; Gui-Shuang Ying; E Revell Martin; Maureen G Maguire
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

3.  Interpretations of fundus autofluorescence from studies of the bisretinoids of the retina.

Authors:  Janet R Sparrow; Kee Dong Yoon; Yalin Wu; Kazunori Yamamoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-09       Impact factor: 4.799

4.  Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial.

Authors:  Wai T Wong; Waynekid Kam; Denise Cunningham; Molly Harrington; Keri Hammel; Catherine B Meyerle; Catherine Cukras; Emily Y Chew; Srinivas R Sadda; Frederick L Ferris
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-23       Impact factor: 4.799

5.  Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography.

Authors:  Zohar Yehoshua; Philip J Rosenfeld; Giovanni Gregori; William J Feuer; Manuel Falcão; Brandon J Lujan; Carmen Puliafito
Journal:  Ophthalmology       Date:  2010-10-29       Impact factor: 12.079

6.  The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials.

Authors:  Janet S Sunness; Eyal Margalit; Divya Srikumaran; Carol A Applegate; Yan Tian; Daniel Perry; Barbara S Hawkins; Neil M Bressler
Journal:  Ophthalmology       Date:  2007-02       Impact factor: 12.079

7.  Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial.

Authors:  Hilary Smolen Brader; Gui-Shuang Ying; E Revell Martin; Maureen G Maguire
Journal:  Ophthalmology       Date:  2013-04-25       Impact factor: 12.079

8.  The epidemiology of progression of pure geographic atrophy: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Stacy M Meuer; Michael D Knudtson; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2008-07-30       Impact factor: 5.258

9.  Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26.

Authors:  Anne S Lindblad; Patricia C Lloyd; Traci E Clemons; Gary R Gensler; Frederick L Ferris; Michael L Klein; Jane R Armstrong
Journal:  Arch Ophthalmol       Date:  2009-09

10.  CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD.

Authors:  Hendrik P N Scholl; Monika Fleckenstein; Lars G Fritsche; Steffen Schmitz-Valckenberg; Arno Göbel; Christine Adrion; Christine Herold; Claudia N Keilhauer; Friederike Mackensen; Andreas Mössner; Daniel Pauleikhoff; Andreas W A Weinberger; Ulrich Mansmann; Frank G Holz; Tim Becker; Bernhard H F Weber
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.